Two-Thirds Of Top 20 Pharmaceutical Companies Have Prohibited AI Brand Engagement Network Aims To Change That Perception With Its Solutions
–News Direct– By Faith Ashmore, Benzinga According to a recent survey conducted by ZoomRx involving 200 professionals in the life sciences industry, over 50% of the respondents indicated that their respective companies had implemented a ban on the usage of ChatGPT, a popular generative artificial intelligence tool developed by OpenAI. Interestingly, around 65% of the…